负荷心肌灌注PET对糖尿病与非糖尿病患者提供增量风险预测
基于多中心注册队列7061例(含1966例糖尿病)的回顾性分析,患者接受临床指征的静息-负荷铷-82心肌灌注PET。调整临床预测因素后,负荷心肌灌注异常程度越高,心脏病死亡风险越大;在糖尿病与非糖尿病患者中,加入灌注成像结果均显著改善临床模型的拟合,且在糖尿病患者中改善了风险重分类。
要点
- 负荷心肌灌注PET结果可为糖尿病和非糖尿病患者提供心脏病死亡的增量风险预测。
- 糖尿病患者中,严重异常心肌较正常心肌的心脏病死亡风险比为7.2(95%CI 3.1, 16.8)。
- 糖尿病患者中,异常心肌灌注PET扫描与心脏病死亡风险增加相关(HR 4.4;95%CI 2.0, 9.7)。
核心结论
- 在因临床指征接受铷-82负荷PET的大队列中,心肌灌注成像结果为糖尿病和非糖尿病患者提供了心脏病死亡的增量风险预测。
研究设计与样本
- 研究为对前瞻性采集数据进行的回顾性分析,来自多中心注册队列,共7061例患者。
- 队列中1966例有糖尿病,平均年龄63.3岁±13,女性3348例(47.4%),已知冠心病2296例(32.5%),既往血运重建1895例(26.8%)。
- 所有患者接受临床指征的静息-负荷铷-82(82Rb)心肌灌注PET。
- 主要终点为心脏病死亡(n=169),平均评估时间2.5年±1.5。
- 采用Cox比例风险模型和风险重分类指标,并按糖尿病状态分层分析。
关键影像表现/征象
- 负荷心肌灌注异常程度增加与心脏病死亡风险增大相关。
诊断标准与关键数值
- 在调整已确立临床预测因素的多变量模型中,糖尿病患者严重异常心肌较正常心肌的心脏病死亡风险比为7.2(95%CI 3.1, 16.8)。
- 加入负荷心肌灌注成像结果显著改善糖尿病和非糖尿病患者预测心脏病死亡的临床模型拟合。
- 心肌灌注PET改善糖尿病患者心脏病死亡的风险重分类,基于类别的净重分类指数为0.39(95%CI 0.15, 0.60,P < .001)。
- 糖尿病患者中,基于年龄、性别、肥胖或既往血运重建定义的所有重要临床亚组内,异常心肌灌注PET扫描与心脏病死亡风险增加相关(HR 4.4;95%CI 2.0, 9.7)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To evaluate the prognostic value of myocardial perfusion PET in patients with and patients without diabetes mellitus.
MATERIALS AND METHODS: The authors performed a retrospective analysis of prospectively acquired data from a multicenter registry cohort of 7061 patients, including 1966 with diabetes mellitus, who underwent clinically indicated rest-stress rubidium 82 (82Rb) myocardial perfusion PET. The mean patient age (±standard deviation) was 63.3 years ± 13. Of the 7061 patients, 3348 were women (47.4%), 2296 (32.5%) had known coronary artery disease, and 1895 (26.8%) had previously undergone revascularization. The primary end point was cardiac death (n = 169) assessed at a mean of 2.5 years ± 1.5. The authors used Cox proportional hazards models and risk reclassification measures stratified according to diabetes status.
RESULTS: In multivariable models adjusting for established clinical predictors, increasing magnitude of stress myocardial perfusion abnormality was associated with greater risk of cardiac death in patients with diabetes (hazard ratio [HR]: 7.2; 95% confidence interval [CI]: 3.1, 16.8) for severely abnormal myocardium compared with normal myocardium. The addition of stress myocardial perfusion imaging results significantly improved the fit of a clinical model for predicting cardiac death in patients with and patients without diabetes. Myocardial perfusion PET improved risk reclassification for cardiac death in patients with diabetes (category-based net reclassification index: 0.39; 95% CI: 0.15, 0.60, P < .001). Among diabetic patients, an abnormal myocardial perfusion PET scan was associated with increased risk of cardiac death (HR: 4.4; 95% CI: 2.0, 9.7) in all important clinical subgroups based on age, sex, obesity, or prior revascularization.
CONCLUSION: In a large cohort of patients referred for clinical 82Rb stress PET, myocardial perfusion imaging results provided incremental risk prediction of cardiac death in patients with and patients without diabetes mellitus.© RSNA, 2019Supplemental material is available for this article.
引用
- Skali H, Di Carli MF, Blankstein R, et al. Stress Myocardial Perfusion PET Provides Incremental Risk Prediction in Patients with and Patients without Diabetes. Radiol Cardiothorac Imaging. 2019. PMID: 33778500. doi:10.1148/ryct.2019180018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。